Trials / Unknown
UnknownNCT05224596
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in GASTRIC Cancer, ASCEND-Gastric
Gastric Cancer Detection by Liquid Biopsy in Peripheral Blood: A Prospective Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 498 (estimated)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
ASCEND-Gastric is a prospective, multi-omics, observational study aimed at detecting gastric cancer by combined assays for serum protein markers, deep sequencing of cell-free DNA (cfDNA), circulating tumor DNA (ctDNA) mutation and circulating RNA. The study will enroll 498 participants, including 128 patients with benign gastric diseases and 370 patients with gastric cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood draw and blood-based biomarkers analyses | blood-based biomarkers analyses |
Timeline
- Start date
- 2021-01-18
- Primary completion
- 2022-05-30
- Completion
- 2022-09-22
- First posted
- 2022-02-04
- Last updated
- 2022-02-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05224596. Inclusion in this directory is not an endorsement.